Detection Technology Oy · OMXHEX:DETEC
Detection Technology Oy — Q1 2022 Earnings Presentation
13 slides from Detection Technology Oy's earnings presentation, Apr 27, 2022
Slide 1: Q1 January–March 2022 Business review
Q1 January–March 2022 Business review President and CEO Hannu Martola | 27 April 2022
Slide 2: Q1 2022 net sales and EBIT
Q1 2022 20.3 10.9 1.5 7.4 net sales, €m net sales change-% EBIT, €m EBIT-% (18.3) (-8.0) (1.4) (7.5) 2 27.4.2022 Detection Technology | Business review January—March 2022
Slide 3: Strong underlying demand, but component shortage postponed sales
Strong underlying demand, but component shortage postponed sales Industrial sales +45% • Demand continued to be strong in all main applications • Even higher potential for growth • Some sales were postponed due to the component shortage Medical sales +5% • Strong CT demand remained unchanged • Escal
Slide 4: Net sales by quarter
Net sales by quarter (EUR 1,000) 30,000 25,000 10.9% 20,000 15,000 (YOY change-%) 10,000 5,000 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 2019 2020 2021 2022 4 27.4.2022 Detection Technology | Business review January—March 2022
Slide 5: Operating profit
Operating profit (EUR 1,000) 6 000 25% 5 000 20% 19.1% 17.5% 4 000 16.7% 15.6% 15% 14.1% 13.4% 3 000 12.3% 12.6% 11.8% 12.0% 10% 2 000 7.5% 7.4% 5.9% 5% 1 000 0 0% Q119 Q219 Q319 Q419 Q120 Q220 Q320 Q420 Q121 Q221 Q321 Q421 Q122 EBIT excluding NRI (EUR 1,000) EBIT-% excluding NRI Mid-term EBIT-targe
Slide 6: Q1 sales split by business units
Q1 sales split by business units NET SALES €m YOY CHANGE-% IBU 3.5 45.2 17.4% 30.9% TOTAL NET SALES 20.3 €m MBU 10.5 4.5 51.8% SBU 6.3 7.5 6 27.4.2022 Detection Technology | Business review January—March 2022
Slide 7: Q1 sales split by region
Q1 sales split by region NET SALES €m YOY CHANGE-% 5.6% 23.3% AMERICAS 1.1 4.8 TOTAL NET SALES 20.3 €m APAC 14.4 3.1 71.1% EMEA 4.7 46.4 7 27.4.2022 Detection Technology | Business review January—March 2022
Slide 8: Key figures
Key figures Q1 2022 Q1 2021 FY 2021 Net sales, EUR 1,000 20,313 18,323 89,813 Change in net sales, % 10.9% -8.0% 10.1% Operating profit, EUR 1,000 1,506 1,382 10,580 Operating margin, % 7.4% 7.5% 11.8% R&D costs, EUR 1,000 2,942 2,405 10,480 R&D costs, % of net sales 14.5% 13.1% 11.7% Cash flow from
Slide 9: Strategy highlights
Strategy highlights Product modifications Carried out a tactical, large-scale project to tackle the component shortage • Includes the entire product portfolio, industrial, medical and security solutions • Completes the first stage by the end of Q2 and the second by the end of Q3 2022. Nanjing talent
Slide 10: Sales expectation Q2 and H2 2022
Sales expectation Q2 and H2 2022 Industrial Medical Security sales to grow sales likely to sales to grow double-digit decline double-digit Demand will continue strongly in all main markets and all three business units in Q2 and H2 2022. Expects double-digit growth in total net sales in H1 and intens
Slide 11: Business outlook
Business outlook SECURITY MARKET annual growth rate • According to Detection Technology’s view, demand will continue to be strong in all of the company’s main 5% markets. • The company expects double-digit growth in net INDUSTRIAL MARKET sales both in Q2 and H2 of 2022, although the annual growth ra
Slide 12: Financial targets
FINANCIAL TARGETS MEDIUM TERM MEDIUM TERM ANNUAL Annual Operating Dividend or sales growth margin returned capital >10% ≥15% 30-60% 12 27.4.2022 Detection Technology | Business review January—March 2022
Slide 13: www.deetee.com
Detection Technology